代谢持续紊乱及代谢亚表型与死亡率和宿主反应蛋白标志物相关
该研究基于一项在美国16个医学中心完成的II期随机对照试验安慰剂组,对72例血管升压药依赖性脓毒性休克且伴中度器官功能障碍的患者,在基线(识别脓毒性休克24小时内)、24小时和48小时纵向检测51种代谢物和10种蛋白分析物。28天前死亡的30例(41.7%)患者基线酰基肉碱和白细胞介素-8(IL-8)升高并持续至T24和T48,丙酮酸、IL-6、肿瘤坏死因子-α和血管生成素-2下降更慢。基线代谢物无监督聚类分出两组,第1组酰基肉碱更高、基线与复苏后器官功能障碍更重(p < 0.05)、1年死亡率更高(p < 0.001)。作者结论认为,脓毒性休克非存活者表现出更显著且持续的中性粒细胞活化相关蛋白分析物失调和线粒体相关代谢紊乱。
要点
- 72例脓毒性休克患者中30例(41.7%)在28天前死亡,死亡者基线酰基肉碱和IL-8升高并持续至T24和T48。
- 死亡者丙酮酸、IL-6、肿瘤坏死因子-α和血管生成素-2的下降速度慢于存活者。
- 基线代谢物聚类第1组酰基肉碱水平更高,基线与复苏后器官功能障碍更重(p < 0.05)。
- 基线代谢物聚类第1组1年死亡率更高(p < 0.001)。
- 作者结论认为非存活者存在更显著且持续的中性粒细胞活化相关蛋白失调和线粒体相关代谢紊乱。
适用人群与场景
- 来自一项已完成的II期随机对照试验安慰剂组,美国16个医学中心。
- 血管升压药依赖性脓毒性休克且伴中度器官功能障碍的患者。
- 血清采集时间为基线(识别脓毒性休克24小时内)、入组后24小时和48小时。
研究设计与关键结果
- 研究设计:对一项II期随机对照试验安慰剂组的患者血清纵向检测51种代谢物和10种蛋白分析物,共72例脓毒性休克患者。
- 28天前死亡30例(41.7%),其基线酰基肉碱和IL-8升高并持续至T24和T48。
- 死亡者丙酮酸、IL-6、肿瘤坏死因子-α和血管生成素-2下降速度慢于存活者。
- 基线代谢物无监督聚类分出两组;第1组酰基肉碱更高、基线与复苏后器官功能障碍更重(p < 0.05)、1年死亡率更高(p < 0.001)。
证据类型、等级与局限
- 证据类型:基于II期随机对照试验安慰剂组的纵向代谢组学与蛋白分析研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Perturbed host metabolism is increasingly recognized as a pillar of sepsis pathogenesis, yet the dynamic alterations in metabolism and its relationship to other components of the host response remain incompletely understood. We sought to identify the early host-metabolic response in patients with septic shock and to explore biophysiological phenotyping and differences in clinical outcomes among metabolic subgroups.
DESIGN: We measured serum metabolites and proteins reflective of the host-immune and endothelial response in patients with septic shock.
SETTING: We considered patients from the placebo arm of a completed phase II, randomized controlled trial conducted at 16 U.S. medical centers. Serum was collected at baseline (within 24 hr of the identification of septic shock), 24-hour, and 48-hour postenrollment. Linear mixed models were built to assess the early trajectory of protein analytes and metabolites stratified by 28-day mortality status. Unsupervised clustering of baseline metabolomics data was conducted to identify subgroups of patients.
PATIENTS: Patients with vasopressor-dependent septic shock and moderate organ dysfunction that were enrolled in the placebo arm of a clinical trial.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Fifty-one metabolites and 10 protein analytes were measured longitudinally in 72 patients with septic shock. In the 30 patients (41.7%) who died prior to 28 days, systemic concentrations of acylcarnitines and interleukin (IL)-8 were elevated at baseline and persisted at T24 and T48 throughout early resuscitation. Concentrations of pyruvate, IL-6, tumor necrosis factor-α, and angiopoietin-2 decreased at a slower rate in patients who died. Two groups emerged from clustering of baseline metabolites. Group 1 was characterized by higher levels of acylcarnitines, greater organ dysfunction at baseline and postresuscitation (p < 0.05), and greater mortality over 1 year (p < 0.001).
CONCLUSIONS: Among patients with septic shock, nonsurvivors exhibited a more profound and persistent dysregulation in protein analytes attributable to neutrophil activation and disruption of mitochondrial-related metabolism than survivors.
参考来源
- Jennaro TS, Puskarich MA, Evans CR, et al. Sustained Perturbation of Metabolism and Metabolic Subphenotypes Are Associated With Mortality and Protein Markers of the Host Response. Crit Care Explor. 2023. PMID: 36998529. doi:10.1097/CCE.0000000000000881
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。